The upgrade from Sell to Hold by a major bank like Deutsche Bank indicates a positive shift in the analyst's view on Acadia Healthcare's future performance. This could lead to increased investor confidence and potentially a more favorable stock price movement in the short term. The maintenance of the $70 price target suggests that the analyst believes the stock is fairly valued at current levels but has reduced downside risk.